CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,035 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02344173
NCT02344173N/ACompleted
CompareCT.gov

ABLATOR Ablation Observational Registry

Abbott Medical Devices·observational·Posted Jan 22, 2015·Updated Jun 5, 2019

In Brief

An observational study for Atrial Fibrillation. Completed, enrolled 2,035 participants across 62 sites in 15 countries.

Detailed Summary

The purpose of this registry is to assess the performance and clinical effectiveness of a combination of SJM mapping and ablation products in the treatment of subjects with atrial fibrillation (AF).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesAustria, Belgium, Canada, China, Czechia, France, Germany, India, Italy, Netherlands, Portugal, Saudi Arabia, South Korea, Spain, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 22, 2015
Enrollment StartNov 1, 2014
Primary CompletionAug 18, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.4 years ago